Skip to main content
14 October 2025
Last updated:
Sunday 12 October 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Oncology review for 2011
Read more
How cannabis medicines gained legitimacy
Read more
UK Biotech needs a subtle culture shift
Read more
Investment pendulum swings back towards biotech
Read more
Europe to tackle antimicrobial resistance
Read more
The perilous state of antibiotic development
Read more
Risk sharing with Pharma -- is this the way to go?
Read more
ADCs propelled back into the oncology spotlight
Read more
Why Oxford BioTherapeutics is targeting ADCs
Read more
How developers approach antibody drug conjugates
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
68
Page
69
Page
70
Page
71
Current page
72
Page
73
Page
74
Page
75
Page
76
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
